Edgewise Therapeutics Inc at Stifel Healthcare Conference Transcript
Thanks, everyone, for being here. Thanks, Kevin, CEO of Edgewise Therapeutics, for being here and walking through this presentation. And we can jump into short Q&A if the time allows. So take it away.
Great. Thanks. Thank you for the invitation. Looking forward to the presentation and tell you about -- a little bit about Edgewise Therapeutics. Here's my disclaimers of what I'll be saying today.
So Edgewise Therapeutics is a muscle physiology platform company looking to treat rare muscle diseases with high unmet medical need. Our first, 5506, we believe can become a foundational medicine for the treatment of all muscular dystrophies.
We have a strong platform in which we invent our drugs against novel targets. We have continuing efforts to look at additional assets from internal research as well as from external business development activities. And we have one of the most seasoned executive teams in the industry that has had success in multiple different
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |